JAZZ
Jazz Pharmaceuticals PLC
238.00$
+0.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -45.5% | +59.7% | +24.0% | +20.3% | 0.0% | +7.8% | -79.3% | +434.1% | -23.6% | +12.6% | +1.8% | – | |
| – | -2.1% | +2.6% | -0.2% | +1.3% | +1.9% | -2.1% | +5.5% | +2.4% | +182.6% | -64.0% | -1.3% | – | |
| – | -5.7% | +16.1% | -7.8% | +5.5% | +17.5% | -3.6% | -4.7% | +36.6% | +126.7% | -62.7% | -1.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | -147.5% | – | – | – | -213.6% | – | -155.6% | – | – | – | |
| – | +135.0% | -31.7% | +2.7% | +52.1% | +23.2% | +192.6% | -69.1% | +26.1% | +333.1% | -70.0% | -8.1% | – | |
| – | – | – | -5.4% | – | -190.3% | -12.6% | +279.5% | -48.9% | +13.5% | – | +188.3% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +34.2% | +0.0% | +61.8% | -7.1% | – | – | – | -100.0% | -100.0% | – | – | – | |
| – | – | – | – | – | -101.9% | +9,677.4% | -99.0% | +0.0% | +0.0% | +0.6% | +12,819.2% | – | |
| – | +27.8% | -43.6% | +184.8% | – | -103.4% | +9,730.4% | -84.7% | -91.3% | – | -204.1% | +1,166.9% | – | |
| – | +238.3% | -85.0% | +130.5% | +1,281.6% | -72.8% | -334.7% | – | – | +64.2% | +496.6% | -149.6% | – | |
| – | -48.1% | +65.6% | +24.6% | +19.6% | -0.7% | +1.5% | -74.2% | +355.4% | -35.4% | +30.9% | +2.3% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.